DC Field | Value | Language |
---|---|---|
dc.contributor.author | E M Ahn | - |
dc.contributor.author | M H Bang | - |
dc.contributor.author | M C Song | - |
dc.contributor.author | M H Park | - |
dc.contributor.author | H Y Kim | - |
dc.contributor.author | Byoung-Mog Kwon | - |
dc.contributor.author | N I Baek | - |
dc.date.accessioned | 2017-04-19T09:05:41Z | - |
dc.date.available | 2017-04-19T09:05:41Z | - |
dc.date.issued | 2006 | - |
dc.identifier.issn | 0253-6269 | - |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/7716 | - |
dc.description.abstract | Ixeris dentata forma albiflora was extracted with 80% aqueous MeOH, and the concentrated extract was partitioned with EtOAc, n-BuOH and H2O. Eight sesquiterpenes were isolated through repeated silica gel and octadecyl silica gel (C18, ODS) column chromatography of the EtOAc and n-BuOH fractions. Physicochemical analysis using NMR, MS and IR revealed the chemical structures of the sesquiterpenes, which were zaluzanin (1), 9a-hydroxyguaian- 4(15),10(14),11(13)-triene-6,12-olide (2), 3β-O-β-D-glucopyranosyl- 8β-hydroxyguaian-4(15),10(14)-diene-6,12-olide (3), 3-O-β-D- glucopyranosyl-8β-hydroxyguauan-10(14)-ene-6,12-olide (4), ixerin M (5), glucozaluzanin C (6), crepiside I (7), and ixerin D (8). This is the first time that these sesquiterpene lactones have been isolated from this plant. Compounds 1, 2 and 7 revealed relatively high cytotoxicities on human colon carcinoma cell and lung adenocarcinoma cell, while compounds 5 and 7 showed acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory activity. | - |
dc.publisher | Pharmaceutical Soc Korea | - |
dc.title | Cytotoxic and ACAT-inhibitory sesquiterpene lactones from the root of lxeris dentata forma albiflora = 세스큐터핀의 세포독성 | - |
dc.title.alternative | Cytotoxic and ACAT-inhibitory sesquiterpene lactones from the root of lxeris dentata forma albiflora | - |
dc.type | Article | - |
dc.citation.title | Archives of Pharmacal Research | - |
dc.citation.number | 11 | - |
dc.citation.endPage | 941 | - |
dc.citation.startPage | 937 | - |
dc.citation.volume | 29 | - |
dc.contributor.affiliatedAuthor | Byoung-Mog Kwon | - |
dc.contributor.alternativeName | 안은미 | - |
dc.contributor.alternativeName | 방명호 | - |
dc.contributor.alternativeName | 송명종 | - |
dc.contributor.alternativeName | 박미현 | - |
dc.contributor.alternativeName | 김화영 | - |
dc.contributor.alternativeName | 권병목 | - |
dc.contributor.alternativeName | 백남인 | - |
dc.identifier.bibliographicCitation | Archives of Pharmacal Research, vol. 29, no. 11, pp. 937-941 | - |
dc.identifier.doi | 10.1007/BF02969274 | - |
dc.subject.keyword | A549 | - |
dc.subject.keyword | ACAT | - |
dc.subject.keyword | HT29 | - |
dc.subject.keyword | Ixeris dentata forma albiflora | - |
dc.subject.keyword | sesquiterpene lactone | - |
dc.subject.local | A549 | - |
dc.subject.local | ACAT (acyl-CoA: cholesterol acyltransferase) | - |
dc.subject.local | Acyl-CoA:cholesterol acyltransferase (ACAT) | - |
dc.subject.local | cholesterol acytransferase (ACAT) | - |
dc.subject.local | Cholestrol Acyl Transferase (ACAT) | - |
dc.subject.local | Acyl CoA: cholesterol acyltransferase (ACAT) | - |
dc.subject.local | ACAT (Acyl-CoA:cholesterol acyltransferase) | - |
dc.subject.local | Acyl-CoA:cholesterol acyltransferase | - |
dc.subject.local | ACAT | - |
dc.subject.local | Acyl-CoA: cholesterol acyltransferase | - |
dc.subject.local | acyl-CoA:cholesterol acyltransferase (ACAT) | - |
dc.subject.local | Acyl-CoA: cholesterol acyltransferase (ACAT) | - |
dc.subject.local | Acyl-coenzyme A: cholesterol acyltransferase (ACAT) | - |
dc.subject.local | Cholesterol acytransferase (ACAT) | - |
dc.subject.local | cholestrol acyl transferase (ACAT) | - |
dc.subject.local | HT29 | - |
dc.subject.local | HT-29 | - |
dc.subject.local | Ixeris dentata forma albiflora | - |
dc.subject.local | sesquiterpene lactone | - |
dc.subject.local | sesquiterpene lactones | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.